NR1I3 and metabolic dysfunction-associated steatotic liver disease: However, no difference in hepatic lipid accumulation was observed between Car+/+ and Car−/− mice, indicating that CAR may be involved in later stages of NAFLD progression and hepatocarcinogenesis (Takizawa et al., 2011).